Endophthalmitis after Uncomplicated Cataract Surgery with the Use of Fourth-Generation Fluoroquinolones. A Retrospective Observational Case Series

Ophthalmology

Volumn 114, Issue 4, 2007, Pages 686-691

  Moshirfar, Majid ^a   Feiz, Vahid ^b   Vitale, Albert T ^a   Wegelin, Jacob A ^c   Basavanthappa, Screenivasa ^a   Wolsey, Darcey H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; MOXIFLOXACIN; QUINOLONE DERIVATIVE;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CASE STUDY; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENDOPHTHALMITIS; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; PHACOEMULSIFICATION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; STREPTOCOCCUS; SURGEON; UNITED STATES; VITREOUS BODY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; AZA COMPOUNDS; BACTERIA; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; QUINOLINES; RETROSPECTIVE STUDIES; VITREOUS BODY;

EID: 33947601439     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.08.038     Document Type: Article

References (36)

1. Aaberg Jr. T.M., Flynn Jr. H.W., Schiffman J., and Newton J. Nosocomial acute-onset postoperative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology 105 (1998) 1004-1010
2. Javitt J.C., Vitale S., Canner J.K., et al. National outcomes of cataract extraction: endophthalmitis following inpatient surgery. Arch Ophthalmol 109 (1991) 1085-1089
3. Lalitha P., Rajagopalan J., Prakash K., et al. Postcataract endophthalmitis in South India. Incidence and outcome. Ophthalmology 112 (2005) 1884-1889
4. Miller J.J., Scott I.U., Flynn Jr. H.W., et al. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 139 (2005) 983-987
5. Versteegh M.F., and Van Rij G. Incidence of endophthalmitis after cataract surgery in the Netherlands: several surgical techniques compared. Doc Ophthalmol 100 (2000) 1-6
6. Barry P., Seal D.V., Gettinby G., et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 32 (2006) 407-410
7. Taban M., Behrens A., Newcomb R.L., et al. Acute endophthalmitis following cataract surgery: a systematic review of the Literature. Arch Ophthalmol 123 (2005) 613-620
8. West E.S., Behrens A., McDonnell P.J., et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology 112 (2005) 1388-1394
9. Speaker M.G., Milch F.A., Shah M.K., et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 98 (1991) 639-649
10. Olson R.J. Reducing the risk of postoperative endophthalmitis. Surv Ophthalmol 49 suppl (2004) S55-S61
11. Liesegang T.J. Use of antimicrobials to prevent postoperative infection in patients with cataracts. Curr Opin Ophthlamol 12 (2001) 68-74
12. Montan P.G., Setterquist H., Marcusson E., et al. Preoperative gentamicin eye drops and chlorhexidine solution in cataract surgery: experimental and clinical results. Eur J Ophthalmol 10 (2000) 286-292
13. Bell T.A., Slack M., Harvey S.G., and Gibson J.R. The effect of trimethoprim-polymyxin B sulphate ophthalmic ointment and chloramphenicol ophthalmic ointment on the bacterial flora of the eye when administered to the operated and unoperated eyes of patients undergoing cataract surgery. Eye 2 (1988) 324-329
14. Jensen M.K., Fiscella R.G., Crandall A.S., et al. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. Am J Ophthalmol 139 (2005) 141-148
15. Mohan N., Gupta V., Tandon R., et al. Topical ciprofloxacin-dexamethasone combination therapy after cataract surgery: randomized controlled clinical trial. J Cataract Refract Surg 27 (2001) 1975-1978
16. Schlech B.A., and Blondeau J. Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX). Surv Ophthalmol 50 suppl 1 (2005) S64-S67
17. Solomon R., Donnenfeld E.D., Perry H.D., et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 112 (2005) 466-469
18. Kim D.H., Stark W.J., O'Brien T.P., and Dick J.D. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology 112 (2005) 1992-1996
19. Stroman D.W., Dajcs J.J., Cupp G.A., and Schlech B.A. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. Surv Ophthalmol 50 suppl (2005) S16-S31
20. Kowalski R.P., Dhaliwal D.K., Karenchak L.M., et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 136 (2003) 500-505
21. Hwang D.G. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol 49 suppl (2004) S79-S83
22. Laird N.M., and Ware J.H. Random-effects models for longitudinal data. Biometrics 38 (1982) 963-974
23. Diggle P.J., Heagerty P., Liang K.Y., and Zeger S.L. Analysis of Longitudinal Data. 2nd ed. (2002), Oxford University Press, Oxford, United Kingdom 169-184
24. Recchia F.M., Busbee B.G., Pearlman R.B., et al. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol 123 (2005) 341-346
25. Han D.P., Wisniewski S.R., Wilson L.A., et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 122 (1996) 1-17
26. Kunimoto D.Y., Das T., Sharma S., et al. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Am J Ophthalmol 128 (1999) 240-242
27. Mino de Kaspar H., Koss M.J., He L., et al. Antibiotic susceptibility of preoperative normal conjunctival bacteria. Am J Ophthalmol 139 (2005) 730-733
28. Moshirfar M., Mirzaian G., Feiz V., and Kang P.C. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J Cataract Refract Surg 32 (2006) 515-518
29. Alexandrakis G., Alfonso E.C., and Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 107 (2000) 1497-1502
30. Goldstein M.H., Kowalski R.P., and Gordon Y.J. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 106 (1999) 1313-1318
31. Cooper B.A., Holekamp N.M., Bohigian G., and Thompson P.A. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol 136 (2003) 300-305
32. Colleaux K.M., and Hamilton W.K. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol 35 (2000) 373-378
33. McDonnell P.J., Taban M., Sarayba M., et al. Dynamic morphology of clear corneal cataract incisions. Ophthalmology 110 (2003) 2342-2348
34. van Belle G. Statistical Rules of Thumb (2002), Wiley Interscience, New York 29-45
35. Ta C.N., Egbert P.R., Singh K., et al. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology 109 (2002) 2036-2040 discussion 2040-1
36. Bucci F.A. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification. Am J Ophthalmol 137 (2004) 308-312